Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Theoretical Biology & Medical Modelling
|
July 23, 2008
Heterogeneity in multistage carcinogenesis and mixture modeling
Sandro Gsteiger, Stephan Morgenthaler
Statistics in Medicine
|
June 1, 2013
Using historical control information for the design and analysis of clinical trials with overdispersed count data
Sandro Gsteiger, Beat Neuenschwander, Francois Mercier, et al.
Pharmaceutical Research
|
October 31, 2009
Bioequivalence tests based on individual estimates using non-compartmental or model-based analyses: evaluation of estimates of sample means and type I error for different designs
Anne Dubois, Sandro Gsteiger, Etienne Pigeolet, et al.
Drugs & Aging
|
September 30, 2016
Effects of Renal Impairment on Steady-State Plasma Concentrations of Rivastigmine: A Population Pharmacokinetic Analysis of Capsule and Patch Formulations in Patients with Alzheimer's Disease
Gilbert Lefèvre, Francesca Callegari, Sandro Gsteiger, et al.
BMC Medical Research Methodology
|
April 2, 2025
Combining treatment effects from mixed populations in meta-analysis: a review of methods
Lorna Wheaton, Sandro Gsteiger, Stephanie Hubbard, et al.
Journal of Market Access & Health Policy
|
November 26, 2024
Technology Assessment vs. Technology Appraisal-How to Strengthen the Science/Value Dichotomy with EU HTA?
Sandro Gsteiger, Heiner C Bucher, James Ryan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 9, 2020
Nonproportional Hazards in Network Meta-Analysis: Efficient Strategies for Model Building and Analysis
Anna Wiksten, Neil Hawkins, Hans-Peter Piepho, et al.
Pharmaceutical Statistics
|
May 20, 2015
Assessing switchability for biosimilar products: modelling approaches applied to children's growth
Rossella Belleli, Roland Fisch, Didier Renard, et al.
Journal of Comparative Effectiveness Research
|
August 8, 2020
Real-world evidence and nonrandomized data in health technology assessment: using existing methods to address unmeasured confounding?
Cormac J Sammon, Thomas P Leahy, Sandro Gsteiger, et al.
Statistics in Medicine
|
July 28, 2011
Model-based analyses of bioequivalence crossover trials using the stochastic approximation expectation maximisation algorithm
Anne Dubois, Marc Lavielle, Sandro Gsteiger, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Theoretical Biology & Medical Modelling
|
July 23, 2008
Heterogeneity in multistage carcinogenesis and mixture modeling
Sandro Gsteiger, Stephan Morgenthaler
Statistics in Medicine
|
June 1, 2013
Using historical control information for the design and analysis of clinical trials with overdispersed count data
Sandro Gsteiger, Beat Neuenschwander, Francois Mercier, et al.
Pharmaceutical Research
|
October 31, 2009
Bioequivalence tests based on individual estimates using non-compartmental or model-based analyses: evaluation of estimates of sample means and type I error for different designs
Anne Dubois, Sandro Gsteiger, Etienne Pigeolet, et al.
Drugs & Aging
|
September 30, 2016
Effects of Renal Impairment on Steady-State Plasma Concentrations of Rivastigmine: A Population Pharmacokinetic Analysis of Capsule and Patch Formulations in Patients with Alzheimer's Disease
Gilbert Lefèvre, Francesca Callegari, Sandro Gsteiger, et al.
BMC Medical Research Methodology
|
April 2, 2025
Combining treatment effects from mixed populations in meta-analysis: a review of methods
Lorna Wheaton, Sandro Gsteiger, Stephanie Hubbard, et al.
Journal of Market Access & Health Policy
|
November 26, 2024
Technology Assessment vs. Technology Appraisal-How to Strengthen the Science/Value Dichotomy with EU HTA?
Sandro Gsteiger, Heiner C Bucher, James Ryan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 9, 2020
Nonproportional Hazards in Network Meta-Analysis: Efficient Strategies for Model Building and Analysis
Anna Wiksten, Neil Hawkins, Hans-Peter Piepho, et al.
Pharmaceutical Statistics
|
May 20, 2015
Assessing switchability for biosimilar products: modelling approaches applied to children's growth
Rossella Belleli, Roland Fisch, Didier Renard, et al.
Journal of Comparative Effectiveness Research
|
August 8, 2020
Real-world evidence and nonrandomized data in health technology assessment: using existing methods to address unmeasured confounding?
Cormac J Sammon, Thomas P Leahy, Sandro Gsteiger, et al.
Statistics in Medicine
|
July 28, 2011
Model-based analyses of bioequivalence crossover trials using the stochastic approximation expectation maximisation algorithm
Anne Dubois, Marc Lavielle, Sandro Gsteiger, et al.
Page
of 3